Piloting Structure-Based Drug Design via Modality-Specific Optimal Schedule

📅 2025-05-12
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
To address the challenge of multimodal modeling—integrating continuous 3D conformations and discrete 2D topologies—in structure-based drug design, this paper introduces VLB-Optimal Scheduling (VOS), a novel noise scheduling paradigm. VOS is the first to theoretically characterize how noise scheduling affects the variational lower bound (VLB) of multimodal probabilistic diffusion paths, overcoming limitations of conventional unimodal scheduling. The method unifies geometric deep learning, multimodal variational inference, and path integral optimization to jointly model atomic coordinates and molecular graphs. Evaluated on the CrossDock benchmark, our approach achieves a PoseBusters pass rate of 95.9%, outperforming strong baselines by over 10%. It further maintains high-affinity prediction accuracy and ensures >99.8% intramolecular structural validity, demonstrating robustness and chemical feasibility.

Technology Category

Application Category

📝 Abstract
Structure-Based Drug Design (SBDD) is crucial for identifying bioactive molecules. Recent deep generative models are faced with challenges in geometric structure modeling. A major bottleneck lies in the twisted probability path of multi-modalities -- continuous 3D positions and discrete 2D topologies -- which jointly determine molecular geometries. By establishing the fact that noise schedules decide the Variational Lower Bound (VLB) for the twisted probability path, we propose VLB-Optimal Scheduling (VOS) strategy in this under-explored area, which optimizes VLB as a path integral for SBDD. Our model effectively enhances molecular geometries and interaction modeling, achieving state-of-the-art PoseBusters passing rate of 95.9% on CrossDock, more than 10% improvement upon strong baselines, while maintaining high affinities and robust intramolecular validity evaluated on held-out test set.
Problem

Research questions and friction points this paper is trying to address.

Challenges in geometric structure modeling for drug design
Twisted probability path of multi-modalities in molecular geometries
Optimizing noise schedules for better molecular interaction modeling
Innovation

Methods, ideas, or system contributions that make the work stand out.

VLB-Optimal Scheduling (VOS) strategy
Optimizes VLB as path integral
Enhances molecular geometry modeling